Clinical Trial Update: An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa [Phase 4]

View source ↗

Summary

This update reports the termination of an 18-month Phase 4 study evaluating joint health in haemophilia A and B patients on prophylaxis with efmoroctocog alfa o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Afstyla (eftrenonacog alfa)
• Eloctate (efmoroctocog alfa)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Hemophilia A, Hemophilia B | Phase 4 | Status: TERMINATED | Results posted: 2025-01-16